The United States liquid biopsy market was valued at US$ 1,376.6 Million in 2024, and the market is projected to reach US$ 3,264.4 Million by 2030. Liquid biopsy tests are employed across healthcare and research settings, including hospitals, physician practices, and diagnostic as well as research laboratories, to analyze the molecular characteristics of cancer. As the second leading cause of mortality in the United States, cancer presents an escalating public health challenge driven by rising incidence rates. According to projections from the National Cancer Institute, approximately 2,041,910 new cancer cases and 618,120 related deaths are expected in 2025. In response to this growing disease burden, research institutions and cancer care organizations are increasingly implementing innovative technologies and patient-centric methodologies aimed at enhancing early detection and improving therapeutic outcomes.

For decades, tissue biopsy has served as the gold standard for cancer diagnosis. However, advancements in liquid biopsy research have positioned it as a credible and effective alternative for cancer detection. The market is anticipated to witness strong growth, driven by several key factors including the advantages of liquid biopsy over traditional solid tumor biopsy, the rising global cancer burden, growing demand for minimally invasive diagnostic procedures, and increasing public and private investment in liquid biopsy research. Additionally, supportive government initiatives are further expected to accelerate market expansion over the forecast period.

Apelo Consulting report titled “United States Liquid Biopsy Market (By Circulating Biomarker, Product, Application, Cancer Types, Non-Cancer Application Types, Clinical Application, End User and Sample Type), Initiatives, Company Profiles, Recent Developments and Market Dynamics – Forecast to 2030” provides a complete assessment of the fast–evolving, high–growth Liquid Biopsy Market landscape.

For more details, please visit: https://apeloconsulting.com/reports/